ARCHIVES

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

This article is from The Cancer Letter archive.

Vol. 22 No. 39 | October 11, 1996

Download PDF Visit The Full Archive

Related Articles

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

NCI Agrees To Offer New Screening RFP In The Future

May 28, 1976

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

NCI-Approved Trials Listed

March 30, 2007

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

January 19, 1996